InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Connolly, Joan. Director active across 1 company, notably enGene Therapeutics Inc.. In total, 1 disclosures have been logged. History available since 16 June 2026. The latest transaction was disclosed on 16 June 2026 (50 - Grant of options). Regulator: SEDI. The full history is openly available.
1 of 1 declaration